drug manufacturing

e6nb38l3ashw90n06iz7eqjji7l2 | PR Fire

Upperton Advances Sterile Manufacturing Facility with MHRA Submission

Upperton has formally submitted its application to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for approval of its 7,000 sq. ft sterile manufacturing facility. This submission follows the successful completion of aseptic process simulation (APS) validation batches executed under the stringent requirements of the revised EU GMP Annex 1 (2023) requirements. Nottingham, UK. […]

Upperton Advances Sterile Manufacturing Facility with MHRA Submission Read More »

jt5665gz910btamco5juoacqzk0n | PR Fire

Upperton Pharma Solutions wins 2025 Integrated Manufacturing Excellence Award

Nottingham, UK. July 7th 2025 – Upperton Pharma Solutions, a leading Nottingham-based pharmaceutical contract development and manufacturing organisation (CDMO), is delighted to announce its recognition as the winner of the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards. Powered by the global insights platform GlobalData, the Pharmaceutical Technology

Upperton Pharma Solutions wins 2025 Integrated Manufacturing Excellence Award Read More »

k4mqloo3awgccfk0pr4towet5v2b | PR Fire

Upperton Pharma Solutions completes build of new £7m sterile manufacturing facility

NOTTINGHAM, UK. January 28th, 2025 – Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of its new sterile manufacturing facility in Nottingham, UK. The new facility is in addition to its existing 50,000 sq. ft facility, Trent Gateway, and the purpose-built facility has been designed specifically in line

Upperton Pharma Solutions completes build of new £7m sterile manufacturing facility Read More »

43y282fkikda1pz2rtpcg77n4r8o | PR Fire

Upperton Joined by Professor Dame Sarah Gilbert To Officially Open New Development and GMP Manufacturing Facility

NOTTINGHAM, UK, 22 March 2024 – UK-based contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech industry representatives and local leaders to celebrate the official opening of a new 50,000 square foot development and GMP manufacturing facility in Nottingham.  In addition to Professor

Upperton Joined by Professor Dame Sarah Gilbert To Officially Open New Development and GMP Manufacturing Facility Read More »